Top Institutions in Dermatology / Oncology
Leading institutions in melanoma research utilize large prospective cohorts, advanced histopathologic analysis, molecular profiling, and longitudinal patient follow-up to identify prognostic factors for melanoma recurrence and improve staging and surveillance strategies.
-
#1
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF is a leader in melanoma research with extensive clinical cohorts and expertise in integrating clinical and pathologic data to refine melanoma staging and recurrence prediction. The institution's involvement in the referenced study highlights its forefront role in this area.
Key Differentiators
- Dermatology
- Oncology
- Surgical Oncology
-
#2
Memorial Sloan Kettering Cancer Center
New York, NY
MSKCC is internationally recognized for its melanoma clinical trials and translational research, particularly in prognostic modeling and sentinel lymph node biopsy techniques that inform recurrence risk.
Key Differentiators
- Dermatology
- Medical Oncology
- Surgical Oncology
-
#3
MD Anderson Cancer Center
Houston, TX
MD Anderson has a robust melanoma program with a focus on integrating clinical, pathologic, and molecular data to predict outcomes and guide surveillance strategies for melanoma patients.
Key Differentiators
- Dermatology
- Medical Oncology
- Surgical Oncology
-
#4
Dana-Farber Cancer Institute / Brigham and Women's Hospital
Boston, MA
Dana-Farber and Brigham and Women's have collaborative melanoma research programs emphasizing biomarker discovery and clinical-pathologic correlations to improve recurrence risk stratification.
Key Differentiators
- Dermatology
- Medical Oncology
- Pathology
-
#5
Johns Hopkins University School of Medicine
Baltimore, MD
Johns Hopkins has a long-standing melanoma research program with expertise in tumor biology, pathology, and clinical outcomes, contributing to improved understanding of recurrence predictors.
Key Differentiators
- Dermatology
- Oncology
- Pathology
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
